Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Fulcrum Therapeutics, Inc. (FULC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/07/2023 |
SC 13G/A
| BlackRock Inc. reports a 2.5% stake in FULCRUM THERAPEUTICS INC |
| 02/14/2023 |
SC 13G/A
| Third Rock Ventures III, L.P. reports a 4.5% stake in Fulcrum Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2023 |
SC 13G/A
| FMR LLC reports a 10.1% stake in FULCRUM THERAPEUTICS INC |
| 01/23/2023 |
SC 13G/A
| Cowen Financial Products LLC reports a 2.6% stake in Fulcrum Therapeutics Inc. |
| 01/06/2023 |
SC 13G/A
| RA CAPITAL MANAGEMENT, L.P. reports a 18.6% stake in FULCRUM THERAPEUTICS, INC. |
| 02/14/2022 |
SC 13G/A
| Third Rock Ventures III, L.P. reports a 10% stake in Fulcrum Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| RTW INVESTMENTS, LP reports a 9.5% stake in Fulcrum Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/27/2021 |
SC 13G/A
| GLAXOSMITHKLINE PLC reports a 4.5% stake in * Fulcrum Therapeutics, Inc. |
| 09/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Foresite Capital Fund IV, L.P. reports a 0% stake in Fulcrum Therapeutics, Inc. |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Foresite Capital Fund IV, L.P. reports a 6.4% stake in Fulcrum Therapeutics, Inc. |
|
|